FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

1179524006: Product containing lidocaine and metronidazole and sucralfate in cutaneous dose form (medicinal product form)


Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Oct 2021. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
4651602015 Lidocaine- and metronidazole- and sucralfate-containing product in cutaneous dose form en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
4651603013 Product containing lidocaine and metronidazole and sucralfate in cutaneous dose form (medicinal product form) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
4651602015 Lidocaine- and metronidazole- and sucralfate-containing product in cutaneous dose form en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
4651603013 Product containing lidocaine and metronidazole and sucralfate in cutaneous dose form (medicinal product form) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core


2 descendants. Search Descendants:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Lidocaine- and metronidazole- and sucralfate-containing product in cutaneous dose form Is a Product containing lidocaine and metronidazole and sucralfate (medicinal product) true Inferred relationship Existential restriction modifier (core metadata concept)
Lidocaine- and metronidazole- and sucralfate-containing product in cutaneous dose form Is a Metronidazole-containing product in cutaneous dose form true Inferred relationship Existential restriction modifier (core metadata concept)
Lidocaine- and metronidazole- and sucralfate-containing product in cutaneous dose form Is a Lidocaine-containing product in cutaneous dose form true Inferred relationship Existential restriction modifier (core metadata concept)
Lidocaine- and metronidazole- and sucralfate-containing product in cutaneous dose form Has manufactured dose form Cutaneous dose form true Inferred relationship Existential restriction modifier (core metadata concept)
Lidocaine- and metronidazole- and sucralfate-containing product in cutaneous dose form Plays role Antibacterial therapeutic role (role) false Inferred relationship Existential restriction modifier (core metadata concept)
Lidocaine- and metronidazole- and sucralfate-containing product in cutaneous dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Metronidazole true Inferred relationship Existential restriction modifier (core metadata concept) 1
Lidocaine- and metronidazole- and sucralfate-containing product in cutaneous dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Sucralfate (substance) true Inferred relationship Existential restriction modifier (core metadata concept) 2
Lidocaine- and metronidazole- and sucralfate-containing product in cutaneous dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Lidocaine true Inferred relationship Existential restriction modifier (core metadata concept) 3

Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing only lidocaine and metronidazole and sucralfate in cutaneous dose form (medicinal product form) Is a True Lidocaine- and metronidazole- and sucralfate-containing product in cutaneous dose form Inferred relationship Existential restriction modifier (core metadata concept)
Lidocaine hydrochloride 40 mg/g and metronidazole 10 mg/g and sucralfate 70 mg/g cutaneous cream Is a True Lidocaine- and metronidazole- and sucralfate-containing product in cutaneous dose form Inferred relationship Existential restriction modifier (core metadata concept)

This concept is not in any reference sets

Back to Start